Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Sep;56(9):727–733. doi: 10.1136/thorax.56.9.727

Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use

G Popescu 1, M Latham 1, V Allgar 1, M Elliott 1
PMCID: PMC1746132  PMID: 11514695

Abstract

BACKGROUND—The sleep apnoea/hypopnoea syndrome (SAHS) is common and treatment with continuous positive airway pressure (CPAP) is effective. However, not all patients can cope with the demands of using mask positive pressure. Compliance can be improved with an intensive educational programme and patient support, but this is not practical in most centres given the large numbers of patients coming forward for treatment. Several studies have evaluated correlations between various parameters at diagnosis in order to anticipate patients' behaviour and to avoid the social and health implications of undertreated SAHS. We have evaluated the use of additional data derived during a 2 week home CPAP trial to identify factors associated with longer term use of CPAP and compliance.
METHODS—Following a diagnostic study, 209 patients were offered a CPAP machine for a 2 week home trial. After completing the trial, patients were reassessed and scored their overall satisfaction with CPAP treatment on a five point scale ranging from "much worse" to "much better" and an Epworth score relating to the loan period. Machine run time was recorded from the integral clock. These data were added to those available at diagnosis to construct models indicative of continuing CPAP and average nightly use at 1year.
RESULTS—209 patients were offered the 2 week loan at least a year before June 1999 (90.9% men, mean (SD) age 51.0 (10.6) years, body mass index (BMI) 34.6 (7.7) kg/m2, Epworth score 15 (IQR 11-18), apnoea/hypopnoea index (AHI) 38.1(22.9) events/h). 153 patients (73.2%) opted to continue CPAP and 56 declined. One year later data were available for 187 patients; 128 (68.5% on an intention to treat analysis) continued to use the machine with a mean use of 5.0 (2.4) hours/night. A logistic regression model indicated that mean CPAP use during the loan period and the overall satisfaction score accurately defined continuing CPAP and "satisfactory" CPAP use at 1 year. For patients with low machine use and no symptomatic improvement during the loan period, the addition of baseline AHI, baseline Epworth score, and the Epworth score at the end of the loan to the equation identifying factors associated with "satisfactory" CPAP use (mean >2 hours/night) improved the value of the model.
CONCLUSION—Data derived from a 2 week CPAP trial are useful in identifying patients who will comply with CPAP treatment to 1 year. It can be used to identify patients with significant symptomatic disease who will struggle with CPAP and may benefit from additional education and support. High mean hourly use and a high degree of overall satisfaction during the loan period identified patients likely to use CPAP and be compliant with it at 1year.



Full Text

The Full Text of this article is available as a PDF (173.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballester E., Badia J. R., Hernández L., Carrasco E., de Pablo J., Fornas C., Rodriguez-Roisin R., Montserrat J. M. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999 Feb;159(2):495–501. doi: 10.1164/ajrccm.159.2.9804061. [DOI] [PubMed] [Google Scholar]
  2. Barbé, Pericás J., Muñoz A., Findley L., Antó J. M., Agustí A. G. Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med. 1998 Jul;158(1):18–22. doi: 10.1164/ajrccm.158.1.9709135. [DOI] [PubMed] [Google Scholar]
  3. Bassetti C., Aldrich M. S. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999 Mar 15;22(2):217–223. doi: 10.1093/sleep/22.2.217. [DOI] [PubMed] [Google Scholar]
  4. Bosley C. M., Fosbury J. A., Cochrane G. M. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995 Jun;8(6):899–904. [PubMed] [Google Scholar]
  5. Brooks D., Horner R. L., Kozar L. F., Render-Teixeira C. L., Phillipson E. A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997 Jan 1;99(1):106–109. doi: 10.1172/JCI119120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cochrane G. M. Therapeutic compliance in asthma; its magnitude and implications. Eur Respir J. 1992 Jan;5(1):122–124. [PubMed] [Google Scholar]
  7. Corden Z. M., Bosley C. M., Rees P. J., Cochrane G. M. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest. 1997 Nov 5;112(5):1278–1282. doi: 10.1378/chest.112.5.1278. [DOI] [PubMed] [Google Scholar]
  8. Coy T. V., Dimsdale J. E., Ancoli-Israel S., Clausen J. L. The role of sleep-disordered breathing in essential hypertension. Chest. 1996 Apr;109(4):890–895. doi: 10.1378/chest.109.4.890. [DOI] [PubMed] [Google Scholar]
  9. Engleman H. M., Kingshott R. N., Wraith P. K., Mackay T. W., Deary I. J., Douglas N. J. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med. 1999 Feb;159(2):461–467. doi: 10.1164/ajrccm.159.2.9803121. [DOI] [PubMed] [Google Scholar]
  10. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997 Feb;52(2):114–119. doi: 10.1136/thx.52.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994 Mar 5;343(8897):572–575. doi: 10.1016/s0140-6736(94)91522-9. [DOI] [PubMed] [Google Scholar]
  12. Engleman H. M., Martin S. E., Douglas N. J. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax. 1994 Mar;49(3):263–266. doi: 10.1136/thx.49.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Engleman H. M., Martin S. E., Kingshott R. N., Mackay T. W., Deary I. J., Douglas N. J. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax. 1998 May;53(5):341–345. doi: 10.1136/thx.53.5.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Howard P., Waterhouse J. C., Billings C. G. Compliance with long-term oxygen therapy by concentrator. Eur Respir J. 1992 Jan;5(1):128–129. [PubMed] [Google Scholar]
  15. Hoy C. J., Vennelle M., Kingshott R. N., Engleman H. M., Douglas N. J. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1096–1100. doi: 10.1164/ajrccm.159.4.9808008. [DOI] [PubMed] [Google Scholar]
  16. Jenkinson C., Davies R. J., Mullins R., Stradling J. R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999 Jun 19;353(9170):2100–2105. doi: 10.1016/S0140-6736(98)10532-9. [DOI] [PubMed] [Google Scholar]
  17. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  18. Keyl C., Lemberger P., Rödig G., Dambacher M., Frey A. W. Changes in cardiac autonomic control during nocturnal repetitive oxygen desaturation episodes in patients with coronary artery disease. J Cardiovasc Risk. 1996 Apr;3(2):221–227. [PubMed] [Google Scholar]
  19. Kribbs N. B., Pack A. I., Kline L. R., Smith P. L., Schwartz A. R., Schubert N. M., Redline S., Henry J. N., Getsy J. E., Dinges D. F. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993 Apr;147(4):887–895. doi: 10.1164/ajrccm/147.4.887. [DOI] [PubMed] [Google Scholar]
  20. Krieger J., Kurtz D., Petiau C., Sforza E., Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep. 1996 Nov;19(9 Suppl):S136–S143. doi: 10.1093/sleep/19.suppl_9.s136. [DOI] [PubMed] [Google Scholar]
  21. Krieger J., Meslier N., Lebrun T., Levy P., Phillip-Joet F., Sailly J. C., Racineux J. L. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. The Working Group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement à Domicile des Insuffisants Respiratoires. Chest. 1997 Dec;112(6):1561–1566. doi: 10.1378/chest.112.6.1561. [DOI] [PubMed] [Google Scholar]
  22. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000 Feb 19;320(7233):479–482. doi: 10.1136/bmj.320.7233.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lindberg E., Janson C., Svärdsudd K., Gislason T., Hetta J., Boman G. Increased mortality among sleepy snorers: a prospective population based study. Thorax. 1998 Aug;53(8):631–637. doi: 10.1136/thx.53.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Loube D. I., Gay P. C., Strohl K. P., Pack A. I., White D. P., Collop N. A. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999 Mar;115(3):863–866. doi: 10.1378/chest.115.3.863. [DOI] [PubMed] [Google Scholar]
  25. McArdle N., Devereux G., Heidarnejad H., Engleman H. M., Mackay T. W., Douglas N. J. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1108–1114. doi: 10.1164/ajrccm.159.4.9807111. [DOI] [PubMed] [Google Scholar]
  26. Meslier N., Lebrun T., Grillier-Lanoir V., Rolland N., Henderick C., Sailly J. C., Racineux J. L. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J. 1998 Jul;12(1):185–192. doi: 10.1183/09031936.98.12010185. [DOI] [PubMed] [Google Scholar]
  27. Meurice J. C., Dore P., Paquereau J., Neau J. P., Ingrand P., Chavagnat J. J., Patte F. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest. 1994 Feb;105(2):429–433. doi: 10.1378/chest.105.2.429. [DOI] [PubMed] [Google Scholar]
  28. Peker Y., Kraiczi H., Hedner J., Löth S., Johansson A., Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 1999 Jul;14(1):179–184. doi: 10.1034/j.1399-3003.1999.14a30.x. [DOI] [PubMed] [Google Scholar]
  29. Pieters T., Collard P., Aubert G., Dury M., Delguste P., Rodenstein D. O. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1996 May;9(5):939–944. doi: 10.1183/09031936.96.09050939. [DOI] [PubMed] [Google Scholar]
  30. Rand C. S., Nides M., Cowles M. K., Wise R. A., Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1995 Aug;152(2):580–588. doi: 10.1164/ajrccm.152.2.7633711. [DOI] [PubMed] [Google Scholar]
  31. Rauscher H., Popp W., Wanke T., Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest. 1991 Oct;100(4):1019–1023. doi: 10.1378/chest.100.4.1019. [DOI] [PubMed] [Google Scholar]
  32. Reeves-Hoche M. K., Meck R., Zwillich C. W. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med. 1994 Jan;149(1):149–154. doi: 10.1164/ajrccm.149.1.8111574. [DOI] [PubMed] [Google Scholar]
  33. Ringbaek T., Lange P., Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respir Med. 1999 May;93(5):333–337. doi: 10.1016/s0954-6111(99)90314-1. [DOI] [PubMed] [Google Scholar]
  34. Rolfe I., Olson L. G., Saunders N. A. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnea. Am Rev Respir Dis. 1991 Nov;144(5):1130–1133. doi: 10.1164/ajrccm/144.5.1130. [DOI] [PubMed] [Google Scholar]
  35. Terán-Santos J., Jiménez-Gómez A., Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med. 1999 Mar 18;340(11):847–851. doi: 10.1056/NEJM199903183401104. [DOI] [PubMed] [Google Scholar]
  36. Turner J., Wright E., Mendella L., Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest. 1995 Aug;108(2):394–400. doi: 10.1378/chest.108.2.394. [DOI] [PubMed] [Google Scholar]
  37. Waldhorn R. E., Herrick T. W., Nguyen M. C., O'Donnell A. E., Sodero J., Potolicchio S. J. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest. 1990 Jan;97(1):33–38. doi: 10.1378/chest.97.1.33. [DOI] [PubMed] [Google Scholar]
  38. Weaver T. E., Kribbs N. B., Pack A. I., Kline L. R., Chugh D. K., Maislin G., Smith P. L., Schwartz A. R., Schubert N. M., Gillen K. A. Night-to-night variability in CPAP use over the first three months of treatment. Sleep. 1997 Apr;20(4):278–283. doi: 10.1093/sleep/20.4.278. [DOI] [PubMed] [Google Scholar]
  39. Wobeser W., Yuan L., Naus M. Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group. CMAJ. 1999 Mar 23;160(6):789–794. [PMC free article] [PubMed] [Google Scholar]
  40. Young T., Blustein J., Finn L., Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep. 1997 Aug;20(8):608–613. doi: 10.1093/sleep/20.8.608. [DOI] [PubMed] [Google Scholar]
  41. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230–1235. doi: 10.1056/NEJM199304293281704. [DOI] [PubMed] [Google Scholar]
  42. Zwarenstein M., Schoeman J. H., Vundule C., Lombard C. J., Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet. 1998 Oct 24;352(9137):1340–1343. doi: 10.1016/S0140-6736(98)04022-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES